MedTrace Logo

Exercise and Mediterranean Diet on Body Composition, Disease Activity and Inflammatory Markers in Rheumatoid Arthritis

NCT02900898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-02-09

No results posted yet for this study

Summary

Rheumatoid arthritis (RA) is a chronic autoimmune disease with metabolic alterations due mainly by the liberation of catabolic cytokines leading to changes in body composition as rheumatoid cachexia. Dynamic exercise (DE) has demonstrated to improve muscular, strength and joint function as well as inflammatory process. Also, a diet focused on the consumption of certain fatty acids like the Mediterranean is recommended to reduce inflammation. The aim of this study is to assess the effect of a dynamic exercise program in combination with a Mediterranean diet in strength, joint mobility and disease activity in women with RA.

Conditions

  • Arthritis, Rheumatoid
  • Dietary Modifications
  • Motor Activity
  • Body Composition, Beneficial
  • Physical Activity
  • Inflammation

Interventions

OTHER

Dynamic exercise and Mediterranean diet

DE, MD

OTHER

Dynamic exercise

DE

OTHER

Mediterranean diet

MD

OTHER

Control

Control

Sponsors & Collaborators

  • LILIA CASTILLO MARTINEz

    lead OTHER

Principal Investigators

  • Juan A Pineda Juárez, PhD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Lilia Castillo Martínez, PhD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Mariel Lozada Mellado, BSc · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Midori Ogata Medel, BSc · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Rocío Cervantes Gaytán, BSc · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Andrea Hinojosa Azaola, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Jorge Alcocer Varela, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Luis Llorente Peters, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Arturo Orea Tejeda, MD · Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02900898 on ClinicalTrials.gov